Louise Jopling

Commercial Director, Eastern Academic Health Science Network

Louise Jopling

Louise holds a PhD in immunology from Imperial College London and drawing on both her background in science and years of experience in drug discovery, development and commercialisation within academia, biotech and pharmaceutical organisations, she leads the commercial team to develop partnerships and support innovators refine their business models, value propositions and navigate the NHS to maximise population benefit and generate economic growth at a regional and national level.

Louise joined Health Innovation East from Johnson and Johnson Innovation, where she led partnership activities across Europe, Middle East and Africa to identify and incubate external assets and capabilities to advance the portfolio of the Immunology Therapy Area for Janssen.

Louise is a board member of the Medtech Accelerator, Strategic Advisor to Enhanc3D Genomics and a mentor on a number of accelerator programmes including Start Codon. She is also a long-standing member of the British Society for Immunology and on the Editorial Board for Immunotherapy Advances journal.

Solving everyday challenges for the rare disease community with tech solutions

Eastern AHSN hosts a live Dragon’s Den Tech Solution Pitching Competition. The rare disease community posed the challenges, community experts have shortlisted, the audience casts the final vote.

My three wishes for the future of rare disease are: Quicker diagnosis; more treatment options; and better awareness across all sectors of society and healthcare.